Most medical device companies begin with an engineer's concept and then search for a clinical problem to fit it. RC Medical, a medical device venture studio based in Lake Forest, California, takes the opposite approach. "We go to the interventional suite first," says David Ferrera, CEO of RC Medical. "The physicians there see the gaps every week. Our job is to listen, then build the company around what they're actually describing." This inversion of the traditional development pipeline is central to the studio's model, which funds, designs, develops, and commercializes products specifically for the interventional radiology market.
Rather than taking on contract work for outside clients, RC Medical partners directly with physician-entrepreneurs to identify new technology and new indications for devices. When an idea clears an early evaluation, the studio forms a standalone company around it. "Each idea gets its own company, its own team, its own focus," Ferrera says. "A big portfolio company can lose a good idea in the shuffle. A newco can't afford to." That approach has already produced three separate companies: Single Pass, Infinity Neuro, and Sonorous NV. Each grew out of a specific problem a physician described in the interventional suite and operates as an independent business rather than a product line inside RC Medical.
The significance of this structure lies in what it captures. Ferrera, who has spent close to three decades building devices for interventional neuroradiology and related fields, including as a co-founder of Blockade Medical and Chief Technology Officer of Balt Global, argues that physicians in these procedures see problems that never make it into a traditional product roadmap. "A catheter that works in a textbook case can still fail in the specific anatomy a physician sees three times a week," he says. "That detail doesn't show up unless you're building with the physician, not for them." By embedding the physician's perspective from the first sketch through commercialization, the studio aims to catch critical design details before a device design is locked in and difficult to change.
The model also redefines the physician's role. A physician who brings an idea to RC Medical is not handing it off and waiting for a report. Ferrera describes the relationship as a partnership that runs from the first sketch through commercialization. "A physician knows the problem better than anyone," he says. "What we bring is the engineering, the regulatory path, and the discipline to turn that problem into something that can actually reach patients. Neither side can do it alone." For ideas that become a new company, the physician's involvement often continues as the product moves through development and toward the market, keeping the clinical need in view at every stage rather than only at the start.
Ferrera is candid that the studio is not the right fit for every idea. "Some ideas are better as a feature of an existing product, not a new company," he says. "Part of the first conversation is being honest about which one this is." That honesty, combined with the studio's willingness to build dedicated companies around validated clinical needs, positions RC Medical as a potential catalyst for innovation in interventional radiology—a field where device limitations can directly affect patient outcomes. The venture studio model, as practiced by RC Medical, suggests that the next generation of interventional radiology devices may come not from a lone engineer's brainstorm but from a structured partnership that starts at the patient's bedside.
